Literature DB >> 17015750

Type I IFN modulates host defense and late hyperinflammation in septic peritonitis.

Heike Weighardt1, Simone Kaiser-Moore, Sylvia Schlautkötter, Tanja Rossmann-Bloeck, Ulrike Schleicher, Christian Bogdan, Bernhard Holzmann.   

Abstract

TLRs are considered important for the control of immune responses during endotoxic shock or polymicrobial sepsis. Signaling by TLRs may proceed through the adapter proteins MyD88 or TIR domain-containing adaptor inducinng IFN-beta. Both pathways can lead to the production of type I IFNs (IFN-alphabeta). In the present study, the role of the type I IFN pathway for host defense and immune pathology in sepsis was investigated using a model of mixed bacterial peritonitis. Systemic levels of IFN-alphabeta protein were markedly elevated during septic peritonitis. More detailed analyses revealed production of IFN-beta, but not IFN-alpha subtypes, and identified CD11b+ CD11c- macrophage-like cells as major producers of IFN-beta. The results further demonstrate that in IFN-alphabeta receptor I chain (IFNARI)-deficient mice, the early recruitment of neutrophils to the infected peritoneal cavity was augmented, most likely due to an increased local production of MCP-1 and leukotriene B4. In the absence of IFNARI, peritoneal neutrophils also exhibited enhanced production of reactive oxygen intermediates and elevated expression of Mac-1. Conversely, administration of recombinant IFN-beta resulted in reduced leukotriene B4 levels and decreased peritoneal neutrophil recruitment and activation. Analysis of the cytokine response to septic peritonitis revealed that IFNARI deficiency strongly attenuated late, but not early, hyperinflammation. In accordance with these findings, bacterial clearance and overall survival of IFNARI(-/-) mice were improved. Therefore, the present study reveals critical functions of the type I IFN pathway during severe mixed bacterial infections leading to sepsis. The results suggest that type I IFN exerts predominantly adverse effects under these conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015750     DOI: 10.4049/jimmunol.177.8.5623

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Contribution of Toll-like receptor activation to lung damage after donor brain death.

Authors:  Anthony J Rostron; David M W Cork; Vassilios S Avlonitis; Andrew J Fisher; John H Dark; John A Kirby
Journal:  Transplantation       Date:  2010-10-15       Impact factor: 4.939

2.  Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites.

Authors:  Lijun Xin; Diego A Vargas-Inchaustegui; Sharon S Raimer; Brent C Kelly; Jiping Hu; Leiyi Zhu; Jiaren Sun; Lynn Soong
Journal:  J Immunol       Date:  2010-05-12       Impact factor: 5.422

3.  Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis.

Authors:  Timo Schwandt; Beatrix Schumak; Gerrit H Gielen; Frank Jüngerkes; Patricia Schmidbauer; Katrin Klocke; Andrea Staratschek-Jox; Niko van Rooijen; Georg Kraal; Isis Ludwig-Portugall; Lars Franken; Sven Wehner; Jörg C Kalff; Olaf Weber; Carsten Kirschning; Christoph Coch; Ulrich Kalinke; Jörg Wenzel; Christian Kurts; Rainer Zawatzky; Bernhard Holzmann; Laura Layland; Joachim L Schultze; Sven Burgdorf; Joke M M den Haan; Percy A Knolle; Andreas Limmer
Journal:  EMBO J       Date:  2011-10-28       Impact factor: 11.598

Review 4.  Newborn susceptibility to infection vs. disease depends on complex in vivo interactions of host and pathogen.

Authors:  Byron Brook; Danny Harbeson; Rym Ben-Othman; Dorothee Viemann; Tobias R Kollmann
Journal:  Semin Immunopathol       Date:  2017-11-02       Impact factor: 9.623

5.  MyD88 and Trif signaling play distinct roles in cardiac dysfunction and mortality during endotoxin shock and polymicrobial sepsis.

Authors:  Yan Feng; Lin Zou; Ming Zhang; Yan Li; Chan Chen; Wei Chao
Journal:  Anesthesiology       Date:  2011-09       Impact factor: 7.892

6.  Toll-like receptor 4 is essential to preserving cardiac function and survival in low-grade polymicrobial sepsis.

Authors:  Ming Zhang; Lin Zou; Yan Feng; Yu-Jung Chen; Qichang Zhou; Fumito Ichinose; Wei Chao
Journal:  Anesthesiology       Date:  2014-12       Impact factor: 7.892

Review 7.  Type I interferon: friend or foe?

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

8.  Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists.

Authors:  James L Wynn; Philip O Scumpia; Robert D Winfield; Matthew J Delano; Kindra Kelly-Scumpia; Tolga Barker; Ricardo Ungaro; Ofer Levy; Lyle L Moldawer
Journal:  Blood       Date:  2008-06-30       Impact factor: 22.113

9.  IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation.

Authors:  Siobhan Smith; Pei Wen Wu; Jane J Seo; Thilini Fernando; Mengyao Jin; Jorge Contreras; Erica N Montano; Joan Ní Gabhann; Kyle Cunningham; Amro Widaa; Eoghan M McCarthy; Eamonn S Molloy; Grainne Kearns; Conor C Murphy; Weiping Kong; Harry Björkbacka; Hardy Kornfeld; Lindsy Forbess; Swamy Venuturupalli; Mariko Ishimori; Daniel Wallace; Michael H Weisman; Caroline A Jefferies
Journal:  JCI Insight       Date:  2018-08-09

10.  Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10.

Authors:  Kindra M Kelly-Scumpia; Philip O Scumpia; Matthew J Delano; Jason S Weinstein; Alex G Cuenca; James L Wynn; Lyle L Moldawer
Journal:  J Exp Med       Date:  2010-01-13       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.